Related Experiment Video
Updated: Jun 26, 2026

In vitro Investigation of the MexAB Efflux Pump From Pseudomonas aeruginosa
Published on: February 17, 2014
Molecular basis of multidrug transport by ABC transporters
Markus A Seeger1, Hendrik W van Veen
1Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, United Kingdom.
Abstract:
Multidrug ABC transporters such as the human multidrug resistance P-glycoprotein (ABCB1) play an important role in the extrusion of drugs from the cell and their overexpression can be a cause of failure of anticancer and antimicrobial chemotherapy. These transport systems contain two nucleotide-binding domains (NBDs) where ATP is bound and hydrolyzed and two membrane domains (MDs) which mediate vectorial transport of substrates across the cell membrane. Recent crystal structures of the bacterial ABCB1 homologues Sav1866 from Staphylococcus aureus and MsbA from Salmonella typhimurium and other organisms shed light on the possible conformational states adopted by multidrug ABC transporters during transport. These structures help to interpret cellular and biochemical data gathered on these transport proteins over the past three decades. However, there are contradictory views on how the catalytic cycle of ATP binding and hydrolysis by the NBDs is linked to the change in drug binding affinity at the MDs, which underlies the capture (high affinity) of the transported drug on one side of the membrane and its release (low affinity) on the other. This review provides an overview of the current evidence for the different transport models and establishes the most recent structure-function relationships in multidrug ABC transporters.
Insights
Multidrug ABC transporters like P-glycoprotein (ABCB1) are key to drug resistance. This review explores how ATP hydrolysis in nucleotide-binding domains (NBDs) links to substrate release in membrane domains (MDs).
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- Multidrug ABC transporters, including P-glycoprotein (ABCB1), mediate drug efflux, contributing to chemotherapy failure.
- These transporters comprise nucleotide-binding domains (NBDs) for ATP binding/hydrolysis and membrane domains (MDs) for substrate transport.
- Overexpression of these transporters is a significant challenge in anticancer and antimicrobial therapies.
Purpose of the Study:
- To review current evidence on transport models for multidrug ABC transporters.
- To elucidate the structure-function relationships governing drug binding and release.
- To reconcile conflicting views on the mechanism linking ATP hydrolysis to substrate transport.
Main Methods:
- Analysis of recent crystal structures of bacterial ABCB1 homologues (e.g., Sav1866, MsbA).
- Integration of structural data with existing cellular and biochemical findings.
- Comparative analysis of different proposed transport models.
Main Results:
- Recent structural data provide insights into the conformational states of multidrug ABC transporters.
- Structural information aids in interpreting decades of biochemical and cellular data.
- Contradictory views exist regarding the coupling of ATP hydrolysis to substrate affinity changes.
Conclusions:
- Understanding the dynamic interplay between NBDs and MDs is crucial for deciphering transporter function.
- Structure-function relationships are key to understanding multidrug resistance mechanisms.
- Further research is needed to fully resolve the catalytic cycle and its link to drug transport.
More Related Videos
06:47ABCG5/G8 Crystallization in a Lipidic Bicelle Environment for X-Ray Crystallography
Published on: August 25, 2023
05:06Characterizing Multidrug Efflux Systems in Acinetobacter baumannii Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
Related Concept Videos
ABC Transporters: Exporter
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Membrane Transporters
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...